Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Antiviral Res. 2021 May 30;193:105084. doi: 10.1016/j.antiviral.2021.105084

Fig. 7.

Fig. 7.

Lead compounds inhibit rCedV replication. HEK 293T cells seeded in a 96-well plate were treated for 1 h at the concentration 10 times exceeding the IC50 concentration of the selected compounds or DMSO. Medium only or medium containing rCedV (MOI: 0.05) was added to the cells. Viral supernatants were collected 48 hpi and titrated by plaque assay to determine infectious virus titer. The data represent mean ± standard error from two independent experiments indicating percent reduction in virus titer relative to the DMSO control (% Reduction in virus titer).